Abstract: A method for positioning a balloon, which is fitted at a distal end of a catheter, at an ostium of a blood vessel of a patient, includes attempting to achieve circumferential physical contact between the balloon and an entire circumference of the ostium. One or more slices across the ostium are imaged with magnetic resonance imaging (MRI), and the extent of blood flow along the circumference of the ostium is estimated using the MRI. Based on the estimated extent of blood flow, an extent of the circumferential physical contact between the balloon and the ostium is indicated to a user.

Abstract: The composite wound dressing apparatus promotes healing of a wound via the use of a vacuum pump. The vacuum pump applies a vacuum pressure to the wound to effectively draw wound fluid or exudate away from the wound bed. The vacuum pump is tethered to the wound dressing and is portable, preferably, carried by the patient in a support bag, which permits patient mobility. Moreover, the patient does not need to be constrained for any period of time while exudate is being removed from the wound.

Abstract: A cervical dilator including a stem comprising a partly or fully dehydrated hydrogel comprising a water-insoluble synthetic hydrophilic polymer capable of radial expansion due to absorption of water from a bodily fluid. The cervical dilator softens and ripens the cervical tissue and expands the cervical canal by a combined action of radial hydrogel stem expansion and osmotic withdrawal of water from the tissue. The osmotic withdrawal is caused by at least one osmotically active compound, such as a water-soluble salt, a polyelectrolyte, or a mixture thereof, wherein the at least one osmotically active compound is dispersed in the hydrogel. The cervical dilator may also include a non-toxic plasticizer of the hydrogel, such as water.

Abstract: A drug delivery device with removable pods is described and related pods methods and systems. The drug delivery device comprises a plurality of receptacles, each receptacle configured to accept a corresponding drug pod, wherein each receptacle comprises: a recess configured to accept a protrusion in the corresponding drug pod, or a protrusion configured to insert in a recess in the corresponding drug pod. The corresponding drug pod comprises a shell, made of an impermeable polymer, having a first base comprising an opening configured to allow delivery of a drug, a second base, a lateral surface, a protrusion attached to, and extending away from, the lateral surface, or a recess in the lateral surface.

Abstract: A cartridge acting as a dispenser for liquid treatments of a human or animal body is U shaped or hoop shape. The cartridge has a container containing a liquid treatment which when required to be dispensed is ejected through one or more nozzles projecting through the wall of the cartridge into the centre of the U or of the hoop. A base is provided for cartridges, the base controlling timing and quantity of treatments.

Abstract: The device includes a dilator having a valve element configured to at least inhibit fluid flow through the dilator in a distal direction, while not inhibiting the passage of articles (e.g., a guidewire) through the dilator in a proximal direction.

Abstract: A venous access port assembly (10) having a housing base (28) with a discharge port (16), a septum (14) and a cap (48). An interior reservoir (22) is defined by a well (30) in the housing base and a bottom (62) of the septum, and a passageway (20) extends from the reservoir through the discharge port (16). The housing base (28) is provided with radiopaque markings (60) on the bottom wall (44) thereof, including radiopaque indicia (70) that identify an attribute of the assembly (10) after its implantation and clearly appear on an X-ray of the patient in a manner informing the radiologist or technologist and the medical practitioner of that particular attribute.

Abstract: The disclosure relates to a subcutaneously implanted port device for establishing access to the vascular system of a patient requiring multiple blood treatments over an extended period of time. The systems, devices and methods disclosed herein may reduce miscannulation, promote intra-session hemostasis, and decrease the incidence of bacteremia and sepsis among other improvements and advantages. The devices include a port with a tapered seat for receiving an access tube, the first tapered seat having a proximal portion, a distal portion, and a conical section extending between the proximal portion and the distal portion; and an interface surface configured to engage a blood vessel or a vascular access catheter. The proximal portion of the tapered seat is configured to receive the access tube therethrough, and the tapered seat creates a mismatch fit with a diameter of the access tube when in use for an increase in flow during treatment.

Abstract: A delivery device for delivering substance to bone includes a luer portion configured to be detachably coupled to a bit driver, the luer portion having a luer thread. A bit portion is rigidly coupled the luer portion, and the bit portion is configured to accommodate the bit driver. A fluted portion is rigidly coupled to the bit portion, the fluted portion comprising a flute, the flute configured to create a hole in the bone. A conduit extends through the luer portion and the bit portion, at least partially through the fluted portion. The flute defines an aperture extending from the conduit entirely through the flute, and the aperture is configured to allow a substance to pass therethrough.

Abstract: A bolus control device for use with an injection device, the bolus control device including a valve body having a proximal end opposite a distal end. The valve body defines a fluid channel therethrough to allow a passage of medical fluid from the proximal end to the distal end. A connector is provided at the proximal end and configured for connecting to a fluid inlet line. A connector subassembly is provided at the distal end and configured for connecting to a fluid outlet line. A compressible check valve is disposed within the fluid channel, such that the compressible check valve is adjustable to control a cracking pressure at which the compressible check valve closes.

Abstract: The invention provides a variety of novel devices, systems, and methods of utilizing mixed-ionic-electronic conductor (MIEC) materials adapted to function with an applied current or potential. The materials, as part of a circuit, are placed in contact with a part of a human or nonhuman animal body. A sodium selective membrane system utilizing the MIEC is also described.

Abstract: A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing, a first prong with a proximal end attached to the housing and a distal end extending away from the housing, a first defibrillator coil on the distal end of the first prong, and a first electrode on the device. The clip is configured to anchor the device to a muscle, a bone, and/or a tissue. The first prong is configured to be positioned inferior to a heart. Therapeutic circuitry in the housing is in electrical communication with the first defibrillator coil and the first electrode and is configured to deliver a shock to the heart through the first defibrillator coil.

Abstract: A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing, a first prong with a proximal end attached to the housing and a distal end extending away from the housing, and a first electrode on the first prong. The clip is configured to anchor the device to a muscle, a bone, and/or a tissue. The first prong is configured to contact a heart. The first electrode is configured to contact the heart. Sensing circuitry in the housing that is configured to sense an electrical signal from the heart, and therapeutic circuitry in the housing is in electrical communication with the first electrode and is configured to deliver electrical stimulation to the heart through the first electrode.

Abstract: A system includes spatially isolated nodes proximal to a cortical surface or spinal cord, a telemetric antenna array located above the dura, the telemetric antenna array configured to provide power to and exchange data with the spatially isolated nodes, and a power and data distribution unit configured to power the spatially isolated nodes, aggregate recorded data, send the aggregated recorded data and commands through a wireless link.

Abstract: Anchoring devices for affixing an implanted lead at a target location in a patient are provided herein. Such anchoring devices include a helical body having a plurality of tines extending laterally outward from the lead when deployed that engage tissue to inhibit axial movement of the implanted lead. The plurality of tines are biased towards the laterally extended deployed configuration and fold inward towards the lead to a delivery configuration to facilitate delivery of the lead through a sheath. The tines may be angled in a proximal direction or in both proximal and distal directions and may include various features to assist in visualization and delivery of the lead.

Abstract: Brain impairment, for example due to stroke, is corrected in order to improve body movement. An fNIRS device is positioned over the motor cortex of non-impaired individuals, and blood oxygen in locations of the brain is analyzed to determine brain activity corresponding to a particular body movement. The movements are statistically analyzed, and are compared with fNIRS data gathered from a movement impaired individual attempting the same movement. A weighted value corresponding to the desired brain activity is generated using the statistical analysis, and is graphically displayed to the movement impaired individual during the attempts. This produces a feedback loop relating to the movement which can be repeated to produce brain plasticity in the impaired individual to facilitate the movement. Additionally, correct brain activity can be used to cause the application of an electrical signal to muscles of the body to produce the desired movement.

Abstract: The invention provides a device for stimulating peripheral nerves, comprising a memory, at least one electrode attached to the patient's body for generating pulses, and a control unit connected with an electrode for setting at least one electrode pulse parameter. The device further includes a detector of response to neuromodulation connected with a control unit for transmitting information on a frequency of movement of at least a part of the body to the control unit, and a controller connected with the control unit for acquiring a user input. The control unit of the device further sets flow of current of electrode pulses automatically, depending on information on a frequency value of movement of a part of the body. The invention further provides a method for treating the syndromes of an overactive bladder using a neuromodulation device. And method of collecting information of such devices.

Abstract: A method for modulating a nerve within a body of a patient includes generating a single signal comprising an electrical impulse, contacting an interface with an outer skin surface of a patient and delivering the electrical impulse from an electrode through the interface and the outer skin surface of the patient to a vagus nerve, thereby modulating the vagus nerve. The electrical impulse may comprise bursts of pulses with a silent intra-burst interval between each of the bursts based on the single signal, wherein each of the bursts has a frequency of about 5 Hz to about 100 Hz and each of the pulses has a duration from about 50 microseconds to about 1000 microseconds. The electrode may be spaced from the interface by a distance of about 0.25 to about 4 times an outer dimension of the interface.

Abstract: Apparatus and methods are described including placing a set of two or more electrodes (22) in electrical contact with a portion of a subject's body. At least one computer processor (24) drives the electrodes to apply an amplitude shift keying signal to the portion of the subject's body, the amplitude shift keying signal containing a high frequency component that acts as a carrier wave, the high frequency component having a frequency of between 80 Hz and 120 Hz, and a low frequency component that acts as a modulating component that modulates the carrier wave, the low frequency component having a frequency of between 1 Hz and 8 Hz. Other applications are also described.

Abstract: The present disclosure provides a method and system for treating affective disorders such as depression and/or anxiety and/or related disorders through neuromodulatory intervention that includes brain targets within the orbitofrontal cortex (OFC). This method includes the application of electrical stimulation through an electrical signal generator device where the distal end of the device comprises at least one stimulating electrode in contact with the OFC. The treatment system includes patient selection, implantation of at least one stimulating electrode in contact with the OFC, acute or chronic electrical stimulation of the OFC, and evaluation of the effects of stimulation on clinical symptoms and status.

Abstract: Transdermal electrical stimulation (TES) applicators that are wearable and configured to attached to a subject's pinna (ear) and adapted to apply TES to modulate the subject's cognitive and/or physiological state. These apparatuses may be configured so that they can be worn against the ear (e.g., the cymba of the ear) to deliver TES. Also described herein are methods of using them to modulate a subject's cognitive state. These TES applicators may also be adapted to function as audio headphones for concurrent delivery of TES and audible signals (e.g., music).

Abstract: A bilateral hearing implant system has a left side and a right side. Left and right side filter bank pre-processors preprocess left and right microphone signals to generate band pass signals for each side. A bilateral signal processing arrangement processes the band pass signals in a time sequence of stimulation frames. The signal processing module includes a bilateral channel selection module synchronously selects for each stimulation frame a set of stimulation channels for each side based on spectral content of the band pass signals. Left and right side signal processing submodules process for each stimulation frame a limited subset of each side band pass signals corresponding to the selected stimulation channels to generate electrical stimulation signals.

Abstract: The techniques described herein are example medical devices, systems, and methods for sensing evoked potentials in a tissue of the patient, and, based on the sensed evoked potentials, adjusting one or more parameters defining the electrical stimulation therapy delivered to the patient. In one example, a system controls delivery of an electrical stimulation therapy from an implantable medical device to a patient according to at least one therapy program, wherein the electrical stimulation therapy is configured to provide pain relief to the patient without substantially resulting in paresthesia perceived by the patient.

Abstract: A system and method for improving heart contractions during a heart function cycle (heartbeat) of a patient requires detecting a local electrical event (depolarization) during the cycle. This local electrical event is then used to trigger a stimulation interval ?t at a time t0. Importantly, the stimulation interval ?t is set to end at a time t1 during the absolute refractory period of the heart function cycle. At the time t1, a stimulator is triggered to stimulate a local sympathetic nerve on the epicardial surface of the heart. With this stimulation the sympathetic nerve secretes norepinephrine to improve a subsequent contraction of the heart.

Abstract: Various aspects of the present subject matter relate to an implantable device. Various device embodiments comprise at least one port to connect to at least one lead with at least electrode, stimulation circuitry connected to the at least one port and adapted to provide at least one neural stimulation therapy to at least one neural stimulation target using the at least one electrode, sensing circuitry connected to the at least one port and adapted to provide a sensed signal, and a controller connected to the stimulation circuitry to provide the at least one neural stimulation therapy and to the sensing circuitry to receive the sensed signal. In response to a triggering event, the controller is adapted to switch between at least two modes. Other aspects and embodiments are provided herein.

Abstract: According to some aspects, a cardiac pacemaker for implantation within a subject is provided, the pacemaker including a housing, at least one sensor configured to detect an activity level of the subject, and at least one processor coupled to the sensor configured to detect inactivity of the subject based on output from the at least one sensor, produce a first signal configured to increase the heart rate of the subject to a first heart rate during a first time period, wherein the first heart rate is above a resting heart rate and below 100 beats per minute, and in response to determining that the first time period has elapsed, producing a second signal configured to increase the heart rate of the subject to a second heart rate during a second time period, wherein the second heart rate is between 100 and 140 beats per minute.

Abstract: The control module of a first pacemaker included in an implantable medical device system including the first pacemaker and a second pacemaker is configured to set a pacing escape interval in response to a far field pacing pulse sensed by the first pacemaker. The far field pacing pulse is a pacing pulse delivered by the second pacemaker. The pacing escape interval is allowed to continue without restarting the in response to a far field intrinsic event sensed by the first pacemaker during the pacing escape interval. The first pacemaker delivers a cardiac pacing pulse to the heart upon expiration of the pacing escape interval.

Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.

Abstract: An assembly for an electrode connection device of an implant has a continuous receiving unit for a plug, a first connecting element which is arranged in a front region of the receiving unit and has at least two flat lateral surfaces, and a second connecting element, which is arranged in a rear region of the receiving unit. The second connecting element includes at least two flat lateral surfaces. Furthermore, an electrode connection device, an implant, and a method for mounting an electrode connection device all utilize the assembly.

Abstract: A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing, and an electrode. The clip is configured to anchor the device to a muscle, a bone, and/or a first tissue. The electrode is configured to contact an organ, a nerve, the first tissue, and/or a second tissue. Circuitry in the housing is in electrical communication with the electrode and is configured to sense an electrical signal from the organ, the nerve, the first tissue, and/or the second tissue through the electrode; deliver electrical stimulation to the organ, the nerve, the first tissue, and/or the second tissue through the electrode; and/or deliver a signal to a drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, the first tissue, and/or the second tissue.

Abstract: A method of subcutaneously injecting and anchoring a device to a bone, a muscle, and/or a tissue in a patient, the device having a clip configured to anchor the device to the bone, the muscle, or the tissue, includes making an incision in the patient. An instrument pre-loaded with the device is inserted through the incision. The instrument is advanced to the bone, the muscle, and/or the tissue upon which the device is to be anchored. A clip of the device is pushed onto the bone, the muscle, and/or the tissue using the instrument. The device is anchored to the bone, the muscle, and/or the tissue using the clip on the device.

Abstract: A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue, and an electrode that is configured to contact an organ, a nerve, the first tissue, and/or a second tissue. The device further includes circuitry in the housing in electrical communication with the electrode that is configured to sense an electrical signal from the organ, the nerve, the first tissue, and/or the second tissue through the electrode; deliver electrical stimulation to the organ, the nerve, the first tissue, and/or the second tissue through the electrode; and/or deliver a signal to a drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, the first tissue, and/or the second tissue.

Abstract: A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing, and an electrode. The clip is configured to anchor the device to a muscle, a bone, and/or a first tissue. The electrode is configured to contact an organ, a nerve, the first tissue, and/or a second tissue. Circuitry in the housing is in electrical communication with the electrode and is configured to sense an electrical signal from the organ, the nerve, the first tissue, and/or the second tissue through the electrode; deliver electrical stimulation to the organ, the nerve, the first tissue, and/or the second tissue through the electrode; and/or deliver a signal to a drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, the first tissue, and/or the second tissue.

Abstract: In some examples, an apparatus configured to be worn by a patient for cardiac defibrillation comprises sensing electrodes configured to sense a cardiac signal of the patient, defibrillation electrodes, therapy delivery circuitry configured to deliver defibrillation therapy to the patient via the defibrillation electrodes, communication circuitry configured to receive data of at least one physiological signal of the patient from at least one sensing device separate from the apparatus, a memory configured to store the data, the cardiac signal, and a machine learning algorithm, and processing circuitry configured to apply the machine learning algorithm to the data and the cardiac signal to probabilistically-determine at least one state of the patient and determine whether to control delivery of the defibrillation therapy based on the at least one probabilistically-determined patient state.

Abstract: Provided is a radiofrequency heating balloon catheter system including a balloon (6) arranged between distal ends of an inner tube (2) and an outer tube (3), an electrode for delivery of radiofrequency current (11) arranged inside the balloon (6), and a temperature sensor (12) arranged at a distal portion of the inner tube inside the balloon in contact with a film of the balloon for estimating the surface temperature of the balloon. Also, the inner tube inside the balloon has a plurality of nozzles (7) bored through in a region extending from the distal portion of the inner tube to the proximal portions thereof to forcibly cool the inside of the balloon and the electrode for delivery of radiofrequency current. This system can be utilized for the application of liminal organs to maintain the surface temperature of the balloon at 45° C. or lower to thereby heat a luminal organ media at a temperature of 45 to 50° C.

Abstract: A system and method for cosmetic treatment of a region of a biological surface using cold atmospheric plasma is presented. In one embodiment, a method of treatment of a region of a biological surface with cold plasma includes: selecting a post-treatment formulation; and applying the post-treatment formulation to the region pre-treated by the cold plasma.

Abstract: Stimulation treatment of medical disorders use stimulation parameters that provide stimulation of a target site directly or create partial stimulation signals that combine into vector signals that stimulate a target site. Stimulation signals have characteristics such as frequency, timing, temporal content that is adjusted for the person being treated. Signals are designed with advantageous characteristics to influence target tissue in an intended manner and avoid producing unwanted side-effects. Stimulation signals are designed to match or avoid internal/endogenous activity (e.g., brain patterns and rhythms) of a patient. Methods for choosing, creating and partial signals are disclosed. Tissue modulation may be accomplished with electrical and/or magnetic stimulation, such as repetitive transcranial magnetic stimulation.

Abstract: It is an aspect of the present invention to provide a method for recording a response to Transcranial Magnetic Stimulation (TMS) utilizing a bi-phasic double pulse pair from a TMS coil device to stimulate a subject wherein the second pulse has a lower amplitude compared to the first pulse in the bi-phasic double pulse pair. Significant advantages are achieved using bi-phasic double pulse pairs, particularly where the second pulse in a pair has an intensity lower than the first. Obtaining measurements is simpler and more accurate as the number and intensity of stimulation can be reduced compared to standard single pulse stimulation.

Abstract: Certain aspects relate to systems and techniques for an orthopedic treatment system. In one aspect, the system includes a body unit configured to attach to an orthopedic bone plate, an electromagnetic field emitter positioned within the body unit, the electromagnetic field emitter configured to project an electromagnetic field at a therapeutic frequency for a therapeutic duration. The system may further include an internal power source positioned within the body unit, the internal power source configured to provide electrical current to the electromagnetic field emitter. The system may also include a receiving coil positioned within the body unit, the receiving coil configured to receive power from an external power source, the external power source positioned outside the body unit.

Abstract: A method of treating pigmented lesions and vascular lesions by a wavelength between 500 nm and 600 nm applied to the segment of skin as a train of pulses. In some examples, a wavelength of 1048 nm is applied sequentially or simultaneously with the wavelength between 500 nm and 600 nm. Disclosed is also an apparatus supporting such skin treatment.

Abstract: A method of and apparatus for processing optical coherence tomography (OCT) scans through a subject's skin, the method comprising, using a computing device (1): receiving a plurality of OCT scans through the subject's skin (7), the OCT scans representing an OCT signal in slices through the subject's tissue; processing the OCT scans to determine a set of parameters; processing each parameter to determine a set of control settings for an energy-delivery device (20); transmitting the control settings from the computing device (1) to the energy-delivery device (20); in which the set of parameters comprises the depth of the superficial plexus (108) through the subject's skin (7).

Abstract: Disclosed is a positioning device for use in a compound portable phototherapy device to contain and enhance therapeutic treatment to a subject. The positioning device comprises an inner surface composed of a non-porous, light reflective material, as well as an outer surface that may be opaque. Use of the positioning device in conjunction with a phototherapy device secures advantages of increased incident light directed on a subject and a controlled thermal environment for the subject. The positioning device may be portable and may be pliable, capable of being rolled or compressed. The positioning device may optionally include a visor, venting, and stabilizing cushioning. The positioning device may optionally include a thermal regulation element.

Abstract: An optical stimulation arrangement including a light-emitting device, implantable in an environment with an associated ground voltage, the light emitting device including: a light emitting element; an anode; and a cathode; and a controller for driving the light-emitting device in a biphasic manner.

Abstract: The invention comprises a method and apparatus for scanning charged particles in a cancer therapy system, comprising the steps of: (1) providing a first and second dipole magnet system and a gap, the gap comprising a common gap length, along a path of the charged particles, within both the first and second dipole magnet systems, the gap comprising a progressively increasing x/y-plane cross-section area from an entrance area of the charged particles into the double dipole magnet system to an exit area of the double dipole magnet system, the x/y-plane perpendicular to a z-axis from a center of the entrance area to a center of the exit area; (2) scanning the positively charged particles along a first axis of the x/y-plane using the first dipole magnet system; and (3) scanning the positively charged particles along a second axis of the x/y-plane using the second dipole magnet system.

Abstract: The present disclosure relates to a system, a method, a computer program and a computer readable medium for determining the thickness of a range shifter to attain target dose coverage in ion beam treatment, wherein the range shifter is for use in a machine for radiation treatment of a target volume, by: receiving, in a processor, input parameters comprising a radiation energy parameter, a range shifter material parameter, object geometry information, and beam characteristic parameters; and further calculating, for each of at least one delivery direction, a range shifter thickness, based on the input parameters, which will deliver the optimum dose conformity.

Abstract: For delivering an image-guided radiation therapy treatment to a moving structure included in a region of a patient body a series of first images of the region of the patient body in different phases of a motion of the structure is acquired in accordance with a first imaging mode. The series of first images is associated with a series of second images of the patient body in essentially the same phases of the motion of the target structure, the second images being acquired in a second imaging mode. During the treatment, a third image is acquired using the second imaging mode during the radiation therapy treatment and a continuation of the radiation therapy treatment is planned on the basis of data relating to one of the first images selected on the basis of a comparison between the third image and the second images associated with the first images.

Abstract: Systems and methods for quality control in image-guided radiotherapy are provided. In some aspects, a method includes acquiring treatment images from a patient using an imaging system, and performing a registration using the treatment images and simulation images acquired during a simulation process. The method also includes computing at least one similarity metric based on the registration performed, and determining a conformance of the at least one similarity metric to predetermined limits. The method further includes generating a report indicative of the conformance.

Abstract: An apparatus for delivery of spatially fractionated radiation treatment to a patient, the apparatus comprising: a radiation source for generating an open radiation beam oriented along a beam axis and having photon energies up to and including a maximum photon energy greater than 0.

Abstract: A method and system of controlling a multi-leaf collimator, wherein steps of the method includes: receiving treatment data, and the treatment data includes position information of N treatment points, conformal position information of N treatment points and radiation field shapes of N treatment points; controlling a treatment head to a conformal position of a first treatment point, and controlling the multi-leaf collimator to begin to conform to a radiation field shape of the first treatment point so as to start a treatment of the first treatment point; controlling the treatment head to a conformal position of a Kth treatment point, and controlling the multi-leaf collimator to begin to conform to a radiation field shape of the Kth treatment point so as to start a treatment of the Kth treatment point; carrying out the described operations repeatedly until the conformation of the radiation field shape and the treatment of all treatment points are completed.

Abstract: An imager includes: an array of imager elements configured to generate image signals based on radiation received by the imager; and circuit configured to perform readout of image signals, wherein the circuit is configured to be radiation hard. An imager includes: an array of imager elements configured to generate image signals based on the radiation received by the imager; and readout and control circuit coupled to the array of imager elements, wherein the readout and control circuit is configured to perform signal readout in synchronization with an operation of a treatment beam source.